DRUG-COATED BALLOONS HEALTHCARE PROFESSIONALS

Indications, Safety, and Warnings   Indications, Safety, and Warnings

In.Pact Admiral DCB

<br><big>THINK </big><br> <big>LONG.</big>

IN.PACT ADMIRAL

DRUG-COATED BALLOON

The IN.PACT™ Admiral™ drug-coated balloon (DCB) is the only available DCB proven through 5 years.1

ACCESS PRODUCT OVERVIEW
Healthcare Professional
light-grey-square

IN.PACT SFA Study 3 out of 4 patient treated with IN.PACT Admiral DCB remain reintervention free through 5 years

PROVEN

THROUGH

5 YEARS<sup>1</sup>


VIew 5-Year Outcomes

Clinical Outcomes

IN.PACT Admiral  DCB demonstrates consistently strong outcomes.

VIew Clinical Outcomes

THE SCIENCE

BEHIND THE OUTCOMES

IN.PACT Admiral DCB increases blood flow and reduces thickening of the artery wall by delivering the proven anti-proliferative drug paclitaxel to the vessel wall.

See DCB Technology
INPACT Admiral In Vessel

Cost Effective Solution

~$1,200

Average saved on follow-up costs through 2 years per patient with IN.PACT Admiral DCB versus standard PTA2

$2,984 vs. $4,196

THE COST-EFFECTIVE SOLUTION

Cost savings from the reduced rates of reintervention and higher rates of clinical efficacy make IN.PACT Admiral DCB the clear choice for patients and physicians. 

View Publication in JACC
Play Video This will play a video - Peripheral Artery Disease: Dr. John Laird, UC Davis Vascular Center

PAD Overview: Dr. John Laird, UC Davis Vascular Center

cobalt-blue-square
Play Video This will play a video - Cost-Effectiveness: Dr. David Cohen, University of Missouri-Kansas City

Cost-Effectiveness: Dr. David Cohen, University of Missouri-Kansas City

light-grey-square
Play Video This will play a video - How IN.PACT Works: Dr. Renu Virmani, CVPath Institute

How IN.PACT Admiral DCB Works: Dr. Renu Virmani, CVPath Institute

Request Information

Request More

Information

Contact Us
1

Laird J. 5-year Results from the IN.PACT SFA Randomized Trial. Presented at VIVA 2018.

2

Cohen D. Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 2-Year Results From the IN.PACT SFA II Trial. Presented at: VIVA 15; Nov. 2-5, 2015; Las Vegas.